Cells (Mar 2021)

Role of Reductive versus Oxidative Stress in Tumor Progression and Anticancer Drug Resistance

  • Kyung-Soo Chun,
  • Do-Hee Kim,
  • Young-Joon Surh

DOI
https://doi.org/10.3390/cells10040758
Journal volume & issue
Vol. 10, no. 4
p. 758

Abstract

Read online

Redox homeostasis is not only essential for the maintenance of normal physiological functions, but also plays an important role in the growth, survival, and therapy resistance of cancer cells. Altered redox balance and consequent disruption of redox signaling are implicated in the proliferation and progression of cancer cells and their resistance to chemo- and radiotherapy. The nuclear factor erythroid 2 p45-related factor (Nrf2) is the principal stress-responsive transcription factor that plays a pivotal role in maintaining cellular redox homeostasis. Aberrant Nrf2 overactivation has been observed in many cancerous and transformed cells. Uncontrolled amplification of Nrf2-mediated antioxidant signaling results in reductive stress. Some metabolic pathways altered due to reductive stress have been identified as major contributors to tumorigenesis. This review highlights the multifaceted role of reductive stress in cancer development and progression.

Keywords